Skeletal muscle-specific overexpression of IGFBP-2 promotes a slower muscle phenotype in healthy but not dystrophic mdx mice and does not affect the dystrophic pathology
Comparative analysis of the IGFBPs in control and dystrophic mouse muscle Increased IGFBP-2 promotes a slower muscle program in control but not mdx mice. Highlights possible role of dystrophin-glycoprotein complex in signaling required for this adaptation